Grasim Industries Approves Rs 3,094 Crore Lyocell Capacity Expansion

₹3,094 Crore investment approved for Phase II Lyocell expansion.
Capacity to reach nearly 210,000 TPA post-expansion.

Reader Takeaway: Significant investment in sustainable fibers; monitor execution and debt levels.

What just happened

Grasim Industries' Board of Directors has approved a capital expenditure of ₹3,094 Crore for Phase II expansion of its Lyocell facility in Harihar, Karnataka. This project will add 110,000 tonnes per annum (TPA) of Lyocell capacity, bringing the total to nearly 210,000 TPA once both phases are complete.

Why this matters

This expansion aligns with Grasim's strategy to capitalize on the growing demand for sustainable textile materials. The company aims to increase the share of its specialty portfolio, which includes Lyocell, Modal, and recycled fibers, to 35% of its business by 2030. The total cellulosic staple fibre (CSF) capacity is targeted to exceed 1 million tonnes annually by 2030.

The backstory

The current expansion follows a Phase I expansion (55,000 TPA) which is already under construction. This strategic move focuses on scaling up production of high-value, future-ready fibers.

What changes now

Phase II will be commissioned in two stages: the first 55,000 TPA line by mid-2028, and the second 55,000 TPA line by mid-2030. Phase I is expected to be operational by mid-2027. This phased approach allows for gradual capacity addition and market absorption.

Risks to watch

Investors should monitor the execution timeline, as the projects span from mid-2027 to 2030. The reliance on a mix of internal accruals and borrowed funds for financing also warrants attention regarding the impact on Grasim's debt profile.

Peer comparison

While specific peer capacity figures are not detailed in the filing, this expansion positions Grasim as a significant player in the Man-Made Cellulosic Fibres (MMCF) segment, focusing on sustainable and specialty offerings.

Context metrics (time-bound)

• Phase I commissioning: Mid-2027
• Phase II (first line) commissioning: Mid-2028
• Phase II (second line) commissioning: Mid-2030
• Specialty portfolio share target: 35% by 2030
• Total CSF capacity target: Over 1 million tonnes annually by 2030

What to track next

Investors should keep an eye on the progress of Phase I and Phase II commissioning milestones and the company's debt levels as the investment is deployed.